Cleared Special

K213800 - Artiglass NRFitTM Tip L.O.R. Glass Syringes (FDA 510(k) Clearance)

May 2022
Decision
164d
Days
Class 2
Risk

K213800 is an FDA 510(k) clearance for the Artiglass NRFitTM Tip L.O.R. Glass Syringes. This device is classified as a Piston Syringe With Neuraxial Connector – Epidural, Peripheral, And/or Indirect Cerebral Spinal Fluid Contact (Class II - Special Controls, product code QEH).

Submitted by Artiglass Srl (Due Carrare, IT). The FDA issued a Cleared decision on May 19, 2022, 164 days after receiving the submission on December 6, 2021.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 880.5860. A Neuraxial Piston Syringe Is Intended To Inject Or Withdraw Fluid From The Neuraxial Space With Neuraxial Specific Connections. This Product Code May Include Epidural, Peripheral, Subarachnoid/spinal Block, Intrathecal And/or Intracerebroventricular Administration Routes. The Connector For Neuraxial Applications Is Intended To Facilitate Ansi/aami/iso 80369-6:2016 Compliant Neuraxial Specific Connections..

Submission Details

510(k) Number K213800 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 06, 2021
Decision Date May 19, 2022
Days to Decision 164 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code QEH - Piston Syringe With Neuraxial Connector – Epidural, Peripheral, And/or Indirect Cerebral Spinal Fluid Contact
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5860
Definition A Neuraxial Piston Syringe Is Intended To Inject Or Withdraw Fluid From The Neuraxial Space With Neuraxial Specific Connections. This Product Code May Include Epidural, Peripheral, Subarachnoid/spinal Block, Intrathecal And/or Intracerebroventricular Administration Routes. The Connector For Neuraxial Applications Is Intended To Facilitate Ansi/aami/iso 80369-6:2016 Compliant Neuraxial Specific Connections.